What is the appropriate aminophylline dosing regimen for a pediatric patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Aminophylline Dosing in Pediatric Patients

For acute severe asthma in children, administer aminophylline as a loading dose of 5 mg/kg IV over 20 minutes (omit if already on theophylline), followed by a continuous infusion of 1 mg/kg/hour. 1, 2

Loading Dose

The standard loading dose is 5 mg/kg administered intravenously over 20 minutes 1, 2. This loading dose should be omitted entirely if the child is already receiving oral theophylline to avoid toxicity 1, 2.

  • The FDA label specifies that 5.7 mg/kg of aminophylline (equivalent to 4.6 mg/kg theophylline) administered over 30 minutes will produce an average serum concentration of 10 mcg/mL (range 6-16 mcg/mL) 3
  • If the patient has received theophylline within 24 hours, obtain an immediate serum level before administering any loading dose 3

Important caveat: Research demonstrates that the traditional 6 mg/kg loading dose frequently produces subtherapeutic levels in children, with 72% of patients having concentrations <10 mg/L within 5.5 hours and 78% requiring additional bolus doses 4. Males and children ≤5 years are particularly likely to have inadequate levels 4.

Maintenance Infusion

Following the loading dose, initiate a continuous infusion of 1 mg/kg/hour 1, 2. This is the guideline-recommended rate for children with acute severe asthma.

The FDA label provides more detailed age-stratified dosing 3:

  • Children 1-9 years: 1.0 mg/kg/hr (as aminophylline)
  • Children 9-12 years: 0.8 mg/kg/hr
  • Adolescents 12-16 years: 0.7 mg/kg/hr
  • Adolescents >16 years (non-smokers): 0.5 mg/kg/hr

Clinical Context and Monitoring

Aminophylline should only be initiated when the child is deteriorating despite optimal first-line therapy (oxygen, nebulized bronchodilators, systemic corticosteroids) 1, 2. The British Thoracic Society guidelines specifically state to start aminophylline infusion when there is "further deterioration" after initial bronchodilator therapy 1.

Monitoring Requirements:

  • Obtain a serum theophylline concentration one expected half-life after starting the infusion (approximately 4 hours in children age 1-9 years) 3
  • Target therapeutic range: 10-20 mcg/mL (though some guidelines suggest 10-15 mcg/mL) 3
  • Additional samples at 12-24 hours, then every 24 hours to adjust for changes 3
  • Monitor for adverse effects, particularly nausea and vomiting (occur 3-5 times more frequently with aminophylline) 5

Dose Adjustments Based on Serum Levels:

The FDA label provides specific adjustment guidance 3:

  • If level <9.9 mcg/mL: Increase infusion rate by 25%
  • If level 10-14.9 mcg/mL: Maintain current rate if tolerated
  • If level 15-19.9 mcg/mL: Consider 10% decrease
  • If level 20-24.9 mcg/mL: Decrease by 25%
  • If level 25-30 mcg/mL: Skip next dose, decrease by 25%
  • If level >30 mcg/mL: Stop infusion, treat overdose

Special Considerations

Children have significantly higher theophylline clearance than adults (mean 84.8 vs 51.4 mL/hr/kg), with younger children (1-9 years) clearing the drug even faster than older children 6. This explains why children require higher mg/kg doses than adults to achieve similar therapeutic levels.

Calculate all doses based on ideal body weight, as theophylline distributes poorly into body fat 3.

Evidence Quality and Limitations

While aminophylline is widely recommended in guidelines for severe pediatric asthma 1, 2, 7, recent systematic reviews reveal limited evidence of benefit in most severity parameters 5. A 2025 meta-analysis found no significant difference in asthma severity scores, hospitalization rates, PICU admissions, or length of stay, though there was a trend toward reduced intubation rates 5. The 2016 systematic review similarly concluded that "currently recommended dosage regimens may not represent the optimum safety and efficacy" 8.

Despite these limitations, aminophylline remains guideline-recommended for life-threatening asthma when first-line therapies fail 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.